SCHEINBERG DAVID A 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Jul 15, 2019
Insider Transaction Report
Form 4
SCHEINBERG DAVID A
Director
Transactions
- Award
Non-Qualified Stock Option (Right to Buy)
2019-07-11+25,000→ 25,000 totalExercise: $5.74Exp: 2029-07-11→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The stock options become exercisable in 12 monthly installments, commencing one month from the grant date.